Carl P. Sherr & Co., LLC Moderna, Inc. Transaction History

Carl P. Sherr & Co., LLC

$179 Million
Q2 2024

A detailed history of Carl P. Sherr & Co., LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Carl P. Sherr & Co., LLC holds 3,043 shares of MRNA stock, worth $200,077. This represents 0.2% of its overall portfolio holdings.

Number of Shares

3,043

Previous 3,043 -0.0%

Holding current value

$200,077

Previous $324,000 11.42%

% of portfolio

0.2%

Previous 0.18%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$69.51 - $104.43 $16,334 - $24,541	-235 Reduced 7.17%	3,043 $302,000
Q3 2023 Nov 03, 2023	BUY	$96.41 - $126.61 $21,306 - $27,980	221 Added 7.23%	3,278 $338,000
Q2 2023 Jul 17, 2023	BUY	$118.5 - $160.53 $32,113 - $43,503	271 Added 9.73%	3,057 $371,000
Q1 2023 May 02, 2023	SELL	$135.66 - $197.02 $61,182 - $88,856	-451 Reduced 13.93%	2,786 $427,000
Q4 2022 Feb 02, 2023	SELL	$118.38 - $210.04 $1,775 - $3,150	-15 Reduced 0.46%	3,237 $581,000
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $17,710 - $29,127	-150 Reduced 4.41%	3,252 $385,000
Q2 2022 Aug 03, 2022	SELL	$117.13 - $176.59 $137,510 - $207,316	-1,174 Reduced 25.66%	3,402 $486,000
Q1 2022 May 03, 2022	SELL	$126.46 - $235.05 $40,340 - $74,980	-319 Reduced 6.52%	4,576 $788,000
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $154,912 - $252,797	-686 Reduced 12.29%	4,895 $1.24 Million
Q3 2021 Nov 03, 2021	SELL	$221.9 - $484.47 $2,884 - $6,298	-13 Reduced 0.23%	5,581 $2.15 Million
Q2 2021 Jul 21, 2021	BUY	$129.91 - $234.98 $34,426 - $62,269	265 Added 4.97%	5,594 $1.31 Million
Q1 2021 Apr 13, 2021	BUY	$109.18 - $185.98 $11,136 - $18,969	102 Added 1.95%	5,329 $698,000
Q4 2020 Feb 08, 2021	BUY	$65.74 - $169.86 $4,864 - $12,569	74 Added 1.44%	5,227 $546,000
Q3 2020 Oct 19, 2020	BUY	$54.34 - $94.85 $280,014 - $488,762	5,153 New	5,153 $365,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carl P. Sherr & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carl P. Sherr & Co., LLC with notifications on news.

Account

Carl P. Sherr & Co., LLC Moderna, Inc. Transaction History